The tool holds promise for increasing efficiency in clinic settings and promoting antibiotic stewardship.
The results of a randomized trial suggests rapid syndromic PCR tests could complement or replace culture-based diagnostic methods for pneumonia.
The portable test from Visby Medical will be able to detect gonorrhea and assess susceptibility to ciprofloxacin.
The funding will support a project to develop diagnostic platforms that can detect drug-resistant infections and identify the right antibiotic in real time.
Lumos Diagnostics receives FDA clearance for a test that helps to determine when antibiotics are needed for respiratory infections.
A randomized controlled trial in Vietnam finds that the use of point-of-care C-reactive protein testing reduced antibiotic prescribing.
The recipients are Vedanta Biosciences, whose lead candidate is a microbiome-directed C difficile therapy, and diagnostics company Pattern Bioscience for rapid bacterial susceptibility tests.
For bacterial infections, the test had a sensitivity of 93% and a specificity of 88%, while viral sensitivity was 70%.
Diagnostics company Avails Medical announced today that it has received an additional $1.7 million in funding from CARB-X (the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) to continue developing a rapid electronic antibiotic susceptibility test (AST).
Becton, Dickinson and Company (BD) and Accelerate Diagnostics yesterday announced a commercial collaboration agreement to bring rapid identification and antibiotic susceptibility tests to more clinicians and patients worldwide.
